Falcon’s Beyond Reports Third Quarter 2026 Financial Results

Falcon's Beyond Global, Inc. (FBYD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Falcon’s Beyond Reports Third Quarter 2026 Financial Results Company Reports Consolidated Revenue of $7.3 Million for Q3 , an 80% increase over prior year. Company's Unconsolidated Subsidiary, Falcon's Creative Group, generated Q3 revenue of $5.2 Million Company's Un

Event · Earnings
Original reporting
Published Nov 12, 2026, 12:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 12:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FBYD
Bearish
medium confidence
Mentioned
$FBYD
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FBYDBearishMed
01

Why it matters

The earnings release provides the first public numbers for the quarter, showing strong revenue growth but widening losses, which may affect short‑term price action.

02

Market read

Primary earnings disclosure for a micro‑cap; relevance driven by fresh financial data rather than sector or macro events.

03

What to watch

Joint‑venture pipeline of $28 M and upcoming VAI project may drive future growth not reflected in current loss.

Relevance 7/10Novelty 7/10Timing: post‑market today

Background

Falcon’s Beyond Global, Inc. (Nasdaq: FBYD) filed a Form 8‑K reporting its third‑quarter 2026 financial results.

Company-level read

Ticker impact

$FBYDBearishMedium confidence
Context

SEC 8‑K reports Q3 2026 results: $7.3 M revenue (+80% YoY), consolidated net loss $7.7 M, adjusted EBITDA loss $7.4 M.

Expected impact

likely downward pressure as investors digest loss despite revenue growth

Evidence & confidence

Small‑cap with limited liquidity; loss magnitude outweighs modest revenue increase.

Market effects

Highlights challenges in niche entertainment‑tech sector; may prompt sector‑wide re‑rating.

Limited to US micro‑cap investors; no broader regional effect.

Minimal global impact given company size.

Counterpoint

Revenue surge could signal upside if loss curve improves; speculative buy on turnaround potential.

Key entities

  • Falcon’s Beyond Global, Inc.

    Entertainment and technology enterprise listed on Nasdaq.

  • Meliá Hotels International

    50:50 joint‑venture partner in Producciones de Parques.

Related articles

$FBYDMed

Falcon’s Beyond Reports Second Quarter 2026 Financial Results

Falcon's Beyond Global, Inc. (FBYD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Falcon’s Beyond Reports Second Quarter 2026 Financial Results Company Reports Consolidated Revenue of $5.6 Million for Q2 Company's Unconsolidated Subsidiary, Falcon's Creative Group, generated Q2 revenue of $12.5 Million Company's Unconsolidated Joint Venture, Produ

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.